TY - JOUR
T1 - Middle and long-term outcomes of dual kidney transplant
T2 - A multicenter experience
AU - Impedovo, S. V.
AU - De Lorenzis, E.
AU - Volpe, A.
AU - Gesualdo, L.
AU - Grandaliano, G.
AU - Palazzo, S.
AU - Lucarelli, G.
AU - Bettocchi, C.
AU - Terrone, C.
AU - Stratta, P.
AU - Quaglia, M.
AU - Battaglia, M.
AU - Ditonno, P.
PY - 2013/4
Y1 - 2013/4
N2 - Introduction: Dual kidney transplantation (DKTx) to reduce the disparity between demand and supply of organs was evaluated in two Italian centers (Bari and Novara). Materials and Methods: Between October 2000 and October 2011, we performed 97 DKT (26 ipsilateral/71 bilateral) following routine biopsy of all kidneys obtained from expanded criteria donors by Remuzzi-Karpinsky scores. The reference group was 379 single grafts from donors older than 60 years single kidney transplantation ([SKT] × > 60). Results: Good postoperative renal function was observed in 56 DKTx (57.7%); whereas acute tubular necrosis requiring dialysis was observed in 41 (42.3%) patients. After a mean follow-up of 60 months, DKTx graft survivals were 96%, 93%, and 90% and patient survivals, 96%, 91%, and 91% at 1, 3, and 5 years, respectively. Complications in expanded criteria donor kidney transplantations included a high rate of cytomegalovirus (CMV) disease especially dual kidney cases. DKTx represented the only independent risk factor for CMV disease upon multivariate analysis (odds ratio [OR] 2.33, 95% confidence interval [CI] 1.28-4.2; P =.006). We did not observe any significant difference in graft or patient survival between DKTx and SKTx > 60 years. Conclusions: We observed good outcomes up to 5 years after transplantation in terms of graft and patient survival despite the use of inferior grafts. Comparing DKTx and SKT > 60, we noted that the mean Karpinski score for SKTx was significantly better than DKTx, although patient and graft survivals were similar. This trend confirms that the use of a biopsy to allocate expanded criteria donor kidneys may be too protective; therefore, the criteria to select DKTx require further refinement.
AB - Introduction: Dual kidney transplantation (DKTx) to reduce the disparity between demand and supply of organs was evaluated in two Italian centers (Bari and Novara). Materials and Methods: Between October 2000 and October 2011, we performed 97 DKT (26 ipsilateral/71 bilateral) following routine biopsy of all kidneys obtained from expanded criteria donors by Remuzzi-Karpinsky scores. The reference group was 379 single grafts from donors older than 60 years single kidney transplantation ([SKT] × > 60). Results: Good postoperative renal function was observed in 56 DKTx (57.7%); whereas acute tubular necrosis requiring dialysis was observed in 41 (42.3%) patients. After a mean follow-up of 60 months, DKTx graft survivals were 96%, 93%, and 90% and patient survivals, 96%, 91%, and 91% at 1, 3, and 5 years, respectively. Complications in expanded criteria donor kidney transplantations included a high rate of cytomegalovirus (CMV) disease especially dual kidney cases. DKTx represented the only independent risk factor for CMV disease upon multivariate analysis (odds ratio [OR] 2.33, 95% confidence interval [CI] 1.28-4.2; P =.006). We did not observe any significant difference in graft or patient survival between DKTx and SKTx > 60 years. Conclusions: We observed good outcomes up to 5 years after transplantation in terms of graft and patient survival despite the use of inferior grafts. Comparing DKTx and SKT > 60, we noted that the mean Karpinski score for SKTx was significantly better than DKTx, although patient and graft survivals were similar. This trend confirms that the use of a biopsy to allocate expanded criteria donor kidneys may be too protective; therefore, the criteria to select DKTx require further refinement.
UR - http://www.scopus.com/inward/record.url?scp=84876832243&partnerID=8YFLogxK
U2 - 10.1016/j.transproceed.2013.02.031
DO - 10.1016/j.transproceed.2013.02.031
M3 - Article
SN - 0041-1345
VL - 45
SP - 1237
EP - 1241
JO - Transplantation Proceedings
JF - Transplantation Proceedings
IS - 3
ER -